دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Fires and their smouldering health effects
doi : 10.1016/S1470-2045(25)00025-7
Volume 26, Issue 2, February 2025, Page 147
The psychological impact of screening with a multicancer early detection test
Solidifying local ablation in the treatment of small-size colorectal liver metastasis
Insights into the future of first-line advanced hepatocellular carcinoma treatment
Transforming oncology care in Latin America: artificial intelligence-driven solutions to bridge workforce gaps
Aromatase inhibitors, cardiovascular medications, and patient outcomes
Aromatase inhibitors, cardiovascular medications, and patient outcomes – Authors' reply
Cancer incidence associated with PFAS contamination of drinking water in the USA
India is boosting vaccination efforts to eradicate cervical cancer
Landscape of subsequent therapies in perioperative immunotherapy trials across multiple cancer types
Psychosocial impact associated with a multicancer early detection test (PATHFINDER): a prospective, multicentre, cohort study
Pembrolizumab with or without bevacizumab in platinum-resistant recurrent or metastatic nasopharyngeal carcinoma: a randomised, open-label, phase 2 trial
Thermal ablation versus surgical resection of small-size colorectal liver metastases (COLLISION): an international, randomised, controlled, phase 3 non-inferiority trial
Ibrutinib plus venetoclax in relapsed or refractory mantle cell lymphoma (SYMPATICO): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
Tiragolumab in combination with atezolizumab and bevacizumab in patients with unresectable, locally advanced or metastatic hepatocellular carcinoma (MORPHEUS-Liver): a randomised, open-label, phase 1b–2, study
Claudin 18.2-targeting antibody–drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial
Global linear accelerator requirements and personalised country recommendations: a cross-sectional, population-based study
Rucaparib versus chemotherapy for treatment of relapsed ovarian cancer with deleterious BRCA1 or BRCA2 mutation (ARIEL4): final results of an international, open-label, randomised, phase 3 trial
Common Sense Oncology principles for the design, analysis, and reporting of phase 3 randomised clinical trials
Management of immune checkpoint inhibitor-associated toxicities in older adults with cancer: recommendations from the International Society of Geriatric Oncology (SIOG)
Differences in the on-label cancer indications of medicinal products between Europe and the USA
Bullous Wells syndrome in a patient with occult nasopharyngeal carcinoma
